0001485003-19-000039.txt : 20190621 0001485003-19-000039.hdr.sgml : 20190621 20190621161049 ACCESSION NUMBER: 0001485003-19-000039 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190619 FILED AS OF DATE: 20190621 DATE AS OF CHANGE: 20190621 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LYNCH DANIEL CENTRAL INDEX KEY: 0001177082 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36296 FILM NUMBER: 19911628 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sesen Bio, Inc. CENTRAL INDEX KEY: 0001485003 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 262025616 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 245 FIRST STREET STREET 2: SUITE 1800 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-444-8550 MAIL ADDRESS: STREET 1: 245 FIRST STREET STREET 2: SUITE 1800 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Eleven Biotherapeutics, Inc. DATE OF NAME CHANGE: 20100223 4 1 wf-form4_156114783468594.xml FORM 4 X0306 4 2019-06-19 0 0001485003 Sesen Bio, Inc. SESN 0001177082 LYNCH DANIEL C/O SESEN BIO, INC. 245 FIRST STREET, SUITE 1800 CAMBRIDGE MA 02142 1 0 0 0 Stock Option 1.48 2019-06-19 4 A 0 52500 0 A 2029-06-18 Common Stock 52500.0 52500 D The option was granted on June 19, 2019 and vests over one year, with 1/12th of the shares subject to the option vesting at the end of each successive one-month period following the grant date until the earlier of a) the day that is one business day prior to the date of the next annual meeting and b) the first anniversary of the grant date, at which time such option shall be fully vested. /s/ Richard F. Fitzgerald as attorney-in-fact 2019-06-21